Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
13.78
-0.19 (-1.36%)
At close: Nov 14, 2025, 4:00 PM EST
13.76
-0.02 (-0.15%)
After-hours: Nov 14, 2025, 7:37 PM EST
Perrigo Company Employees
Perrigo Company had 8,379 employees as of December 31, 2024. The number of employees decreased by 761 or -8.33% compared to the previous year.
Employees
8,379
Change (1Y)
-761
Growth (1Y)
-8.33%
Revenue / Employee
$511,016
Profits / Employee
-$6,182
Market Cap
1.90B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8,379 | -761 | -8.33% |
| Dec 31, 2023 | 9,140 | 240 | 2.70% |
| Dec 31, 2022 | 8,900 | -1,000 | -10.10% |
| Dec 31, 2021 | 9,900 | -1,600 | -13.91% |
| Dec 31, 2020 | 11,500 | 300 | 2.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PRGO News
- 10 days ago - Perrigo Company plc (PRGO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Perrigo begins strategic review of baby formula business - Reuters
- 10 days ago - Perrigo Reports Third Quarter 2025 Financial Results From Continuing Operations - PRNewsWire
- 10 days ago - Perrigo to Conduct Strategic Review of its Infant Formula Business - PRNewsWire
- 11 days ago - Perrigo to Attend Jefferies Consumer Conference - PRNewsWire
- 14 days ago - Drugmakers must face skincare drug price-fixing lawsuit, US judge rules - Reuters
- 17 days ago - Perrigo Announces Quarterly Dividend - PRNewsWire
- 18 days ago - 49 October Hi-Yield S&P Aristocrats: 5 To Buy - Seeking Alpha